Figure 1.
Characteristics and outcomes according to IDH mutation status at diagnosis. (A) Comutations in patients with IDH mutation (ie, IDH1 R132, IDH2 R140, IDH2 R172) and wild-type at diagnosis (n = 125) consolidated by HSCT. (B) BM VAF at diagnosis according to IDH mutation status. (C) CIR, (D) EFS, and (E) OS of HSCT-consolidated patients with AML according to IDH mutation status.

Characteristics and outcomes according to IDH mutation status at diagnosis. (A) Comutations in patients with IDH mutation (ie, IDH1 R132, IDH2 R140, IDH2 R172) and wild-type at diagnosis (n = 125) consolidated by HSCT. (B) BM VAF at diagnosis according to IDH mutation status. (C) CIR, (D) EFS, and (E) OS of HSCT-consolidated patients with AML according to IDH mutation status.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal